mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for KHK
Gene summary
Basic gene Info.Gene symbolKHK
Gene nameketohexokinase (fructokinase)
Synonyms-
CytomapUCSC genome browser: 2p23.3
Type of geneprotein-coding
RefGenesNM_000221.2,
NM_006488.2,
Descriptionhepatic fructokinaseketohexokinase
Modification date20141207
dbXrefs MIM : 614058
HGNC : HGNC
Ensembl : ENSG00000138030
HPRD : 11774
Vega : OTTHUMG00000097077
ProteinUniProt: P50053
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_KHK
BioGPS: 3795
PathwayNCI Pathway Interaction Database: KHK
KEGG: KHK
REACTOME: KHK
Pathway Commons: KHK
ContextiHOP: KHK
ligand binding site mutation search in PubMed: KHK
UCL Cancer Institute: KHK
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0046835carbohydrate phosphorylation22371574


Top
Ligand binding site mutations for KHK
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
A230A232SHNSC1
G40Q38RKIRC1
A230A232SLUSC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for KHK
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
A230A232S-1.2237501
G40Q38R-0.93223242
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for KHK from PDB

Top
Differential gene expression and gene-gene network for KHK
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of KHK and the right PPI network was created from samples without mutations in the LBS of KHK. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for KHK
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0268160Fructosuria3Biomarker, GeneticVariation
umls:C1416630FRUCTOSURIA, ESSENTIAL1GeneticVariation

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for KHK
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of KHK go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
TR3N-[3-(METHYLSULFANYL)-1-PHENYL-1H-INDAZOL-6-YL]PIPERIDINE-4-CARBOXAMIDE3nc9AA230
XNBN~8~-(CYCLOPROPYLMETHYL)-N~4~-[2-(METHYLSULFANYL)PHENYL]-2-(PIPERAZIN-1-YL)PYRIMIDO[5,4-D]PYRIMIDINE-4,8-DIAMINE3q92AA230
XNNN~8~-(CYCLOPROPYLMETHYL)-2-(2,6-DIAZASPIRO[3.3]HEPT-2-YL)-N~4~-[2-(METHYLSULFANYL)PHENYL]PYRIMIDO[5,4-D]PYRIMIDINE-4,8-DIAMINE3qaiAA230
FRUFRUCTOSE2hw1AG40
FRUFRUCTOSE3nbvAG40


Top
Conservation information for LBS of KHK
Multiple alignments for P50053 in multiple species
LBSAA sequence# speciesSpecies
A224AVLVCAWAEEG1Homo sapiens
A224ATLVCAWAEEG1Mus musculus
A224ATLICAWAEEG1Rattus norvegicus
A226LVCAWAEEGAD2Homo sapiens, Mus musculus
A226LICAWAEEGAD1Rattus norvegicus
A230WAEEGADALGP3Homo sapiens, Mus musculus, Rattus norvegicus
A244LLHSDAFPPPR3Homo sapiens, Mus musculus, Rattus norvegicus
A256VDTLGAGDTFN3Homo sapiens, Mus musculus, Rattus norvegicus
A285FGCQVAGKKCG3Homo sapiens, Mus musculus, Rattus norvegicus
C282ALRFGCQVAGK3Homo sapiens, Mus musculus, Rattus norvegicus
C289VAGKKCGLQGF3Homo sapiens, Mus musculus, Rattus norvegicus
D15GLVVLDIINVV2Mus musculus, Rattus norvegicus
D15GLVVLDVISLV1Homo sapiens
D258TLGAGDTFNAS3Homo sapiens, Mus musculus, Rattus norvegicus
E227VCAWAEEGADA2Homo sapiens, Mus musculus
E227ICAWAEEGADA1Rattus norvegicus
F245LHSDAFPPPRV3Homo sapiens, Mus musculus, Rattus norvegicus
F260GAGDTFNASVI3Homo sapiens, Mus musculus, Rattus norvegicus
G229AWAEEGADALG3Homo sapiens, Mus musculus, Rattus norvegicus
G255VVDTLGAGDTF3Homo sapiens, Mus musculus, Rattus norvegicus
G257DTLGAGDTFNA3Homo sapiens, Mus musculus, Rattus norvegicus
G286GCQVAGKKCGL3Homo sapiens, Mus musculus, Rattus norvegicus
G40QRWQRGGNASN3Homo sapiens, Mus musculus, Rattus norvegicus
G41RWQRGGNASNS3Homo sapiens, Mus musculus, Rattus norvegicus
K193VVFVSKDVAKH3Homo sapiens, Mus musculus, Rattus norvegicus
L112SRTIILYDTNL2Mus musculus, Rattus norvegicus
L112NRTIVLHDTSL1Homo sapiens
L254RVVDTLGAGDT3Homo sapiens, Mus musculus, Rattus norvegicus
N107NNSNGSRTIIL2Mus musculus, Rattus norvegicus
N107NNSNGNRTIVL1Homo sapiens
N42WQRGGNASNSC3Homo sapiens, Mus musculus, Rattus norvegicus
N45GGNASNSCTVL3Homo sapiens, Mus musculus, Rattus norvegicus
P246HSDAFPPPRVV3Homo sapiens, Mus musculus, Rattus norvegicus
P247SDAFPPPRVVD3Homo sapiens, Mus musculus, Rattus norvegicus
R108NSNGSRTIILY2Mus musculus, Rattus norvegicus
R108NSNGNRTIVLH1Homo sapiens
T253PRVVDTLGAGD3Homo sapiens, Mus musculus, Rattus norvegicus
V13CVGLVVLDIIN2Mus musculus, Rattus norvegicus
V13CVGLVVLDVIS1Homo sapiens
V250FPPPRVVDTLG3Homo sapiens, Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas